- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in the domestic and international market.The company is a part of RPG group which is a diversified conglomerate with interests in areas of infrastructure, tyres, information technology, pharmaceuticals, energy and plantations.The group is headed by Harsh Goenka.
RPG Life Sciences has strategically spun off its Active Pharmaceutical Ingredients (API) business into a new subsidiary, RPG Active Pharma (RPGAP). This move aims for sharper focus and growth. The API unit recorded ~95.1 Cr in external sales in FY26, specializing in high-value niche products. In a key development, RPGAP...
RPG Life Sciences Limited will host a virtual investors/analysts group call on Thursday, September 3, 2026, at 04:00 PM IST. The call will discuss the Company's recent strategic announcement. Dial-in details and the investor presentation will be shared separately.
RPG Life Sciences' subsidiary RPG Active Pharma acquired Raghava Life Sciences' API business for up to ₹135 crore. This expands RPGAP's integrated API capabilities, adding 22 commercialized APIs, 7 in development, and ~300 KL manufacturing capacity from an EU-GMP facility.